10q10k10q10k.net

vs

Side-by-side financial comparison of Align Technology (ALGN) and Danaher Corporation (DHR), based on the latest 10-Q / 10-K filings. Click either name above to swap in a different company.

Danaher Corporation is the larger business by last-quarter revenue ($6.8B vs $1.0B, roughly 6.5× Align Technology). Danaher Corporation runs the higher net margin — 13.0% vs 17.5%, a 4.5% gap on every dollar of revenue. On growth, Align Technology posted the faster year-over-year revenue change (5.3% vs 4.6%). Danaher Corporation produced more free cash flow last quarter ($1.7B vs $187.3M). Over the past eight quarters, Danaher Corporation's revenue compounded faster (8.6% CAGR vs 2.5%).

Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandib...

Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments,...

ALGN vs DHR — Head-to-Head

Bigger by revenue
DHR
DHR
6.5× larger
DHR
$6.8B
$1.0B
ALGN
Growing faster (revenue YoY)
ALGN
ALGN
+0.7% gap
ALGN
5.3%
4.6%
DHR
Higher net margin
DHR
DHR
4.5% more per $
DHR
17.5%
13.0%
ALGN
More free cash flow
DHR
DHR
$1.6B more FCF
DHR
$1.7B
$187.3M
ALGN
Faster 2-yr revenue CAGR
DHR
DHR
Annualised
DHR
8.6%
2.5%
ALGN

Income Statement — Q4 2025 vs Q4 2025

Metric
ALGN
ALGN
DHR
DHR
Revenue
$1.0B
$6.8B
Net Profit
$135.8M
$1.2B
Gross Margin
65.3%
58.0%
Operating Margin
14.8%
22.0%
Net Margin
13.0%
17.5%
Revenue YoY
5.3%
4.6%
Net Profit YoY
30.8%
10.2%
EPS (diluted)
$1.88
$1.69

Green = leading value per metric. Periods may differ when fiscal calendars don't align — see 8-quarter trend below.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history — bar widths are scaled to the larger of the two companies so you can eyeball the size gap and growth trajectory without doing math. Quarters aligned by calendar period (report date) so offset fiscal years line up.

Revenue
ALGN
ALGN
DHR
DHR
Q4 25
$1.0B
$6.8B
Q3 25
$995.7M
$6.1B
Q2 25
$1.0B
$5.9B
Q1 25
$979.3M
$5.7B
Q4 24
$995.2M
$6.5B
Q3 24
$977.9M
$5.8B
Q2 24
$1.0B
$5.7B
Q1 24
$997.4M
$5.8B
Net Profit
ALGN
ALGN
DHR
DHR
Q4 25
$135.8M
$1.2B
Q3 25
$56.8M
$908.0M
Q2 25
$124.6M
$555.0M
Q1 25
$93.2M
$954.0M
Q4 24
$103.8M
$1.1B
Q3 24
$116.0M
$818.0M
Q2 24
$96.6M
$907.0M
Q1 24
$105.0M
$1.1B
Gross Margin
ALGN
ALGN
DHR
DHR
Q4 25
65.3%
58.0%
Q3 25
64.2%
58.2%
Q2 25
69.9%
59.3%
Q1 25
69.5%
61.2%
Q4 24
70.0%
59.5%
Q3 24
69.7%
58.7%
Q2 24
70.3%
59.7%
Q1 24
70.0%
60.2%
Operating Margin
ALGN
ALGN
DHR
DHR
Q4 25
14.8%
22.0%
Q3 25
9.7%
19.1%
Q2 25
16.1%
12.8%
Q1 25
13.4%
22.2%
Q4 24
14.5%
21.8%
Q3 24
16.6%
16.5%
Q2 24
14.3%
20.3%
Q1 24
15.5%
22.6%
Net Margin
ALGN
ALGN
DHR
DHR
Q4 25
13.0%
17.5%
Q3 25
5.7%
15.0%
Q2 25
12.3%
9.3%
Q1 25
9.5%
16.6%
Q4 24
10.4%
16.6%
Q3 24
11.9%
14.1%
Q2 24
9.4%
15.8%
Q1 24
10.5%
18.8%
EPS (diluted)
ALGN
ALGN
DHR
DHR
Q4 25
$1.88
$1.69
Q3 25
$0.78
$1.27
Q2 25
$1.72
$0.77
Q1 25
$1.27
$1.32
Q4 24
$1.40
$1.50
Q3 24
$1.55
$1.12
Q2 24
$1.28
$1.22
Q1 24
$1.39
$1.45

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest filing — the kind of financial-strength check premium terminals charge for.

Metric
ALGN
ALGN
DHR
DHR
Cash + ST InvestmentsLiquidity on hand
$1.1B
Total DebtLower is stronger
$18.4B
Stockholders' EquityBook value
$4.0B
$52.5B
Total Assets
$6.2B
$83.5B
Debt / EquityLower = less leverage
0.35×

8-quarter trend — quarters aligned by calendar period so offset fiscal years match up.

Cash + ST Investments
ALGN
ALGN
DHR
DHR
Q4 25
$1.1B
Q3 25
$1.0B
Q2 25
$901.2M
Q1 25
$873.0M
Q4 24
$1.0B
Q3 24
$1.0B
Q2 24
$761.4M
Q1 24
$865.8M
Total Debt
ALGN
ALGN
DHR
DHR
Q4 25
$18.4B
Q3 25
$16.9B
Q2 25
$17.4B
Q1 25
$16.5B
Q4 24
$16.0B
Q3 24
$17.5B
Q2 24
$17.0B
Q1 24
$18.2B
Stockholders' Equity
ALGN
ALGN
DHR
DHR
Q4 25
$4.0B
$52.5B
Q3 25
$4.0B
$51.1B
Q2 25
$3.9B
$52.3B
Q1 25
$3.8B
$50.8B
Q4 24
$3.9B
$49.5B
Q3 24
$3.9B
$51.3B
Q2 24
$3.8B
$49.9B
Q1 24
$3.8B
$53.4B
Total Assets
ALGN
ALGN
DHR
DHR
Q4 25
$6.2B
$83.5B
Q3 25
$6.2B
$79.9B
Q2 25
$6.2B
$81.6B
Q1 25
$6.1B
$79.1B
Q4 24
$6.2B
$77.5B
Q3 24
$6.4B
$80.6B
Q2 24
$6.2B
$78.6B
Q1 24
$6.2B
$83.4B
Debt / Equity
ALGN
ALGN
DHR
DHR
Q4 25
0.35×
Q3 25
0.33×
Q2 25
0.33×
Q1 25
0.32×
Q4 24
0.32×
Q3 24
0.34×
Q2 24
0.34×
Q1 24
0.34×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Net income can be massaged; cash flow is harder to fake.

Metric
ALGN
ALGN
DHR
DHR
Operating Cash FlowLast quarter
$223.2M
$2.1B
Free Cash FlowOCF − Capex
$187.3M
$1.7B
FCF MarginFCF / Revenue
17.9%
25.5%
Capex IntensityCapex / Revenue; lower = less reinvestment burden
3.4%
5.4%
Cash ConversionOCF / Net Profit; >1× = earnings back up with cash
1.64×
1.77×
TTM Free Cash FlowTrailing 4 quarters
$490.8M
$5.3B

8-quarter trend — quarters aligned by calendar period so offset fiscal years match up.

Operating Cash Flow
ALGN
ALGN
DHR
DHR
Q4 25
$223.2M
$2.1B
Q3 25
$188.7M
$1.7B
Q2 25
$128.7M
$1.3B
Q1 25
$52.7M
$1.3B
Q4 24
$286.1M
$2.0B
Q3 24
$263.7M
$1.5B
Q2 24
$159.8M
$1.4B
Q1 24
$28.7M
$1.7B
Free Cash Flow
ALGN
ALGN
DHR
DHR
Q4 25
$187.3M
$1.7B
Q3 25
$169.0M
$1.4B
Q2 25
$107.2M
$1.1B
Q1 25
$27.4M
$1.1B
Q4 24
$263.1M
$1.5B
Q3 24
$233.9M
$1.2B
Q2 24
$106.4M
$1.1B
Q1 24
$19.3M
$1.4B
FCF Margin
ALGN
ALGN
DHR
DHR
Q4 25
17.9%
25.5%
Q3 25
17.0%
22.6%
Q2 25
10.6%
18.4%
Q1 25
2.8%
18.4%
Q4 24
26.4%
23.0%
Q3 24
23.9%
21.0%
Q2 24
10.3%
19.7%
Q1 24
1.9%
25.0%
Capex Intensity
ALGN
ALGN
DHR
DHR
Q4 25
3.4%
5.4%
Q3 25
2.0%
4.8%
Q2 25
2.1%
4.2%
Q1 25
2.6%
4.3%
Q4 24
2.3%
7.9%
Q3 24
3.0%
5.1%
Q2 24
5.2%
5.0%
Q1 24
0.9%
5.0%
Cash Conversion
ALGN
ALGN
DHR
DHR
Q4 25
1.64×
1.77×
Q3 25
3.33×
1.83×
Q2 25
1.03×
2.41×
Q1 25
0.57×
1.36×
Q4 24
2.76×
1.86×
Q3 24
2.27×
1.85×
Q2 24
1.66×
1.56×
Q1 24
0.27×
1.60×

Financial Flow Comparison

Sankey diagram of revenue → gross profit → operating profit → net profit for each company. Charts shown full-width and stacked so both segment hierarchies are readable side-by-side on desktop and mobile.

Related Comparisons